U.S.-Based Magrathea Launches Next-Gen Magnesium Production Technology, Advances Plans to Scale
Implementing technical initiatives to further improve cost and environmental efficiencies of proven technology
Technology enables American companies to secure a reliable critical mineral supply to counter trade policies and export controls
SAN FRANCISCO, May 28, 2025--(BUSINESS WIRE)--Magrathea ("Magrathea" or the "Company"), a technology company that produces magnesium metal from seawater, today announced the launch of its next-generation magnesium chloride electrolyzer, a machine that uses electricity to split magnesium salts to make magnesium metal, at its pilot facility in Oakland, California. This milestone is a crucial step to advance the technical and data framework for a future scaled plant. Additionally, the project strategically positions Magrathea's technology to provide American companies with access to U.S.-based critical mineral supply chains amid shifting trade policies and export controls.
"Magnesium is one of the most important critical materials, but NATO countries face a dire shortage of non-China supply," Alex Grant, CEO of Magrathea, said. "Western nations must view this supply crisis as a national security emergency."
"At our core, Magrathea's innovative technology revitalizes a proven process with our own twist for considerable efficiency improvement and expense reduction," Mr. Grant continued. "We expect to reduce the technology's operating expenses to make it cost-competitive with alternative production methods that exist today, including in China. Magrathea is in conversations with several major defense, chemical and mining industrial players to form a strategic partnership to scale up our technology as the first new commercial-scale magnesium electrolyzer in the United States in the past 50 years."
Over the coming months, Magrathea will use data gathered from the pilot-scale electrolyzer to create a scalable technical model aimed at achieving the highest efficiencies from both environmental and economic perspectives. The Company will focus on obtaining process data, minimizing total electricity use, recycling energy in strategic ways and optimizing the dehydration process, which offers the biggest opportunity for cost reduction in the electrolytic magnesium metal production process. These technical efforts are expected to significantly reduce the carbon footprint and operating expenditure of future commercial plants. The data and key processing learnings are also expected to help streamline permitting processes for future facilities given the inherent environmental benefits of the technology.
Magrathea and Magnesium Highlights
The "Gateway Metal": Magnesium unlocks a wide range of applications, such as stiffening aluminum in alloys, steel making, nuclear inputs, automotive, aerospace, and next-generation defense applications.
Solving a National Security Emergency: Russia and China currently control 90% of the global primary magnesium supply with no significant producer in any NATO country.
First Mover Advantage: Magrathea is the most advanced new producer of magnesium metal with significant intellectual property including patents and trade secrets.
Existing Operations: Magrathea's operational pilot plant in California can produce 4,000 pounds of magnesium annually at full capacity.
Low Operational Expense: Magrathea's technology demonstrates competitive operating costs, leveraging abundantly available seawater and renewable energy as feedstock.
Carbon Neutral: Technology produces 0 kg CO2 eq./kg magnesium compared to over 40 kg CO2 eq./kg magnesium with the incumbent Chinese process, which is expected to further streamline permitting processes for future scaled facilities.
Scalable to Meet Demand: Magrathea – in partnership with a strategic partner – plans to deploy its technology at a scaled facility by 2027 to produce up to 2 million pounds of magnesium per year, enough to support the equivalent production of thousands of Black Hawk helicopters annually.
Significant Commercial Traction: Magrathea has signed agreements with more than 25 companies, including 10 connected to the U.S. defense industry, an offtake agreement with a global automaker, and a resource supply agreement with Cargill.
Additional Market Opportunities: In addition to magnesium, Magrathea produces chloride co-products, which have a wide range of end-markets such as bleach, to unlock more value and improve project economics.
Strong Engineering Partnership: Magrathea is collaborating with Sedgman Novopro, an engineering firm specialized in mining and mineral processing, to support its scale-up engineering and design program.
Backed By Marquee Investors: Technology is backed by credible investors, including the U.S. Department of Defense, Capricorn, VoLo Earth, Exor Ventures, Sam Altman, and leaders at Glencore, Mitra Chem, Tesla, and many more.
About Magrathea
Magrathea is a technology company based in California that has developed a process for making magnesium metal from seawater and brines to help the West solve its magnesium shortage. Magnesium is essential for a wide range of applications such as stiffening aluminum in alloys, steel making, inputs for nuclear applications, automotive, aerospace, and next-generation defense applications. The company's technology is expected to be the largest primary production solution across NATO countries by 2030. For more information, please visit https://www.magratheametals.com/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250528694331/en/
Contacts
Mediamedia@magratheametals.com

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Data Sovereignty Shapes Netherlands Cloud Strategies
Enterprises adopt hybrid and multicloud architectures for data protection, flexibility, edge computing, ISG Provider Lens® report says AMSTERDAM, August 05, 2025--(BUSINESS WIRE)--Enterprises in the Netherlands are shifting to hybrid and multicloud environments for agility, security and compliance, according to a new research report published today by Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm. The 2025 ISG Provider Lens® Private/Hybrid Cloud — Data Center Services report for the Netherlands finds demand for sovereign cloud solutions rising as data protection and digital sovereignty mandates grow stricter and more coordinated. Dutch enterprises, particularly in regulated sectors such as healthcare, finance and government, are seeking cloud architectures that ensure sensitive data remains within national boundaries. "The Dutch market is experiencing rapid growth in sovereign and hybrid cloud adoption," said Anthony Drake, partner at ISG. "This trend aligns closely with sustainability initiatives that are also influencing data center investments." The Netherlands is emerging as a leading European market for colocation and edge computing, driven by enterprise demand for secure, sustainable and compliant data centers, the report says. As edge computing grows, many organizations are also using colocation centers for faster data processing that is available closer to users. Sustainability goals are driving Dutch enterprises toward green data center operations, with more than 80 percent of centers already powered by renewable energy, ISG says. Enterprises adopt measures such as advanced cooling technologies, waste heat reuse and renewable energy integration to enhance operational efficiency, comply with environmental laws and meet national climate targets. Many Dutch companies are adopting advanced technologies such as AI, ML and real-time monitoring to strengthen cloud operations and security, the report says. Industries including healthcare and finance embrace robust security models such as zero trust to protect complex cloud environments. Amid this evolution, providers are addressing skills shortages by expanding managed services and automation, helping clients address cloud complexity. Enterprises in the Netherlands increasingly seek flexible, customized cloud solutions that go beyond basic infrastructure to support efficient workload migration, seamless integration and enhanced security for sensitive data, ISG says. Companies need these environments to ensure greater operational control, improved performance and adherence to evolving data protection regulations. "Dutch enterprises are prioritizing adaptable cloud strategies to navigate changing technology demands," said Meenakshi Srivastava, lead analyst, ISG Provider Lens Research, and lead author of the report. "They prefer tailored services that simplify compliance while providing strong protection." The report also explores other cloud trends in the Netherlands, including the requirement for cloud portability and interoperability to avoid vendor lock-in and the deployment of adaptive AI solutions to streamline complex business processes. For more insights into the cloud-related challenges faced by Dutch enterprises, along with ISG's advice for addressing them, see the ISG Provider Lens® Focal Points briefing here. The 2025 ISG Provider Lens® Private/Hybrid Cloud — Data Center Services report for the Netherlands evaluates the capabilities of 48 providers across three quadrants: Managed Services, Colocation Services and AI-Ready Infrastructure Consulting. The report names Accenture, Capgemini, Kyndryl and TCS as Leaders in two quadrants each. Atos, Cognizant, CyrusOne, Digital Realty, DXC Technology, Equinix, Eurofiber Cloud Infra, maincubes, NorthC Datacenters, NTT DATA, QTS and Wipro are named as Leaders in one quadrant each. In addition, LTIMindtree and nLighten are named as Rising Stars — companies with a "promising portfolio" and "high future potential" by ISG's definition — in one quadrant each. In the area of customer experience, Persistent Systems is named the global ISG CX Star Performer for 2025 among private/hybrid cloud and data center service providers. Persistent Systems earned the highest customer satisfaction scores in ISG's Voice of the Customer survey, part of the ISG Star of Excellence™ program, the premier quality recognition for the technology and business services industry. The 2025 ISG Provider Lens® Private/Hybrid Cloud — Data Center Services report for the Netherlands is available to subscribers or for one-time purchase on this webpage. About ISG Provider Lens® Research The ISG Provider Lens® Quadrant research series is the only service provider evaluation of its kind to combine empirical, data-driven research and market analysis with the real-world experience and observations of ISG's global advisory team. Enterprises will find a wealth of detailed data and market analysis to help guide their selection of appropriate sourcing partners, while ISG advisors use the reports to validate their own market knowledge and make recommendations to ISG's enterprise clients. The research currently covers providers offering their services globally, across Europe, as well as in the U.S., Canada, Mexico, Brazil, the U.K., France, Benelux, Germany, Switzerland, the Nordics, Australia and Singapore/Malaysia, with additional markets to be added in the future. For more information about ISG Provider Lens research, please visit this webpage. About ISG ISG (Nasdaq: III) is a global AI-centered technology research and advisory firm. A trusted partner to more than 900 clients, including 75 of the world's top 100 enterprises, ISG is a long-time leader in technology and business services that is now at the forefront of leveraging AI to help organizations achieve operational excellence and faster growth. The firm, founded in 2006, is known for its proprietary market data, in-depth knowledge of provider ecosystems, and the expertise of its 1,600 professionals worldwide working together to help clients maximize the value of their technology investments. View source version on Contacts Press Contacts: Laura Hupprich, ISG+1 203 517 Philipp Jaensch, ISG+49 151 730 365 Sign in to access your portfolio


Business Wire
25 minutes ago
- Business Wire
Polpharma Biologics and Fresenius Kabi Sign Licensing Agreement for Proposed Vedolizumab Biosimilar PB016
AMSTERDAM, ZUG, Switzerland & GDAŃSK, Poland--(BUSINESS WIRE)--Polpharma Biologics S.A. ('Polpharma Biologics') announces a global (except for Middle East & North Africa) licensing agreement with Fresenius Kabi for the commercialization of PB016, a proposed biosimilar to vedolizumab, an integrin receptor antagonist, (reference product: Entyvio®*), a biologic therapy indicated for moderate to severe ulcerative colitis and Crohn's disease. Under the terms of the agreement, Polpharma Biologics will lead development and manufacturing of PB016, while Fresenius Kabi will hold exclusive commercialization rights worldwide, excluding Middle East & North Africa. 'This partnership reinforces our mission to broaden access to high-quality biologics that improve patient outcomes globally,' said Konstantin Matentzoglu, Supervisory Board Member of Polpharma Biologics Group. 'Fresenius Kabi's deep commercialization experience and commitment to biosimilars make them an ideal partner for bringing PB016 to patients worldwide. Together, we are taking an important step toward addressing the rising burden of chronic inflammatory diseases.' The agreement builds on Polpharma Biologics' growing biosimilar portfolio and proven development capabilities. The company has previously brought forward multiple biosimilars — including ranibizumab and natalizumab — across global markets in partnership with leading pharmaceutical companies. This strategic collaboration strengthens both companies' commitments to expanding global access to affordable biologic medicines while supporting healthcare system sustainability. *Entyvio® is a registered trademark of Takeda. About Polpharma Biologics: Polpharma Biologics is an international biotechnology company with integrated operations in the European Union (EU), developing and manufacturing biosimilar medicines. Using patented solutions and state-of-the-art platform technologies, Polpharma Biologics develops biosimilar products to treat a range of conditions in major therapeutic areas. Programs at Polpharma Biologics start in cell line development and transition through technical and clinical development to commercial-scale production preparing drugs for future commercial partnerships with global pharmaceutical organizations. The expertise of Polpharma Biologics lies in the development and manufacture of medicines based on microbial and mammalian expression systems. With its cell line development center in the Netherlands and two centers of development and manufacturing in Poland, Polpharma Biologics creates growth and development opportunities for biotechnology specialists. Learn more at About Fresenius Kabi: As part of the global healthcare company Fresenius, Fresenius Kabi specializes in (bio)pharmaceuticals, medical technologies and nutrition products for critical and chronic conditions. The company's products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With more than 41,000 employees and present in over 100 countries, Fresenius Kabi's expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies. For more information, please visit Important Note This press release is for informational purposes only and does not constitute promotional material for PB016 in Poland or any other jurisdiction. The commercialization of proposed vedolizumab biosimilar PB016 is solely the responsibility of Fresenius Kabi, the marketing authorization holder, in accordance with all applicable laws and regulations. Disclaimer This press release is issued from Polpharma Biologics Group and is intended to provide worldwide information to healthcare professionals, media and (potential) investors about our global business in relation to drug development and manufacturing expertise. Although Polpharma Biologics Group is not a public company as of this date, recipients should understand that this press release contains certain forward-looking statements (as defined in the U.S. Private Securities Litigation Reform Act of 1995). These statements involve inherent risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, the approval and commercialization of the medicinal product, market reception, competition, changes in economic conditions and applicable laws, global regulatory developments, contractual risks and dependencies from third parties. Polpharma Biologics undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release. Moreover, Polpharma Biologics wishes to emphasize that this press release is for informational purposes only and shall not be construed as making any representation, warranties, or guarantees, either express or implied, regarding the potential approval, market reception, commercialization, or success of the medicinal product or any other product or therapy.


Business Wire
25 minutes ago
- Business Wire
Data Sovereignty Shapes Netherlands Cloud Strategies
AMSTERDAM--(BUSINESS WIRE)--Enterprises in the Netherlands are shifting to hybrid and multicloud environments for agility, security and compliance, according to a new research report published today by Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm. The Dutch market is experiencing rapid growth in sovereign and hybrid cloud adoption. This trend aligns closely with sustainability initiatives that are also influencing data center investments. The 2025 ISG Provider Lens® Private/Hybrid Cloud — Data Center Services report for the Netherlands finds demand for sovereign cloud solutions rising as data protection and digital sovereignty mandates grow stricter and more coordinated. Dutch enterprises, particularly in regulated sectors such as healthcare, finance and government, are seeking cloud architectures that ensure sensitive data remains within national boundaries. 'The Dutch market is experiencing rapid growth in sovereign and hybrid cloud adoption,' said Anthony Drake, partner at ISG. 'This trend aligns closely with sustainability initiatives that are also influencing data center investments.' The Netherlands is emerging as a leading European market for colocation and edge computing, driven by enterprise demand for secure, sustainable and compliant data centers, the report says. As edge computing grows, many organizations are also using colocation centers for faster data processing that is available closer to users. Sustainability goals are driving Dutch enterprises toward green data center operations, with more than 80 percent of centers already powered by renewable energy, ISG says. Enterprises adopt measures such as advanced cooling technologies, waste heat reuse and renewable energy integration to enhance operational efficiency, comply with environmental laws and meet national climate targets. Many Dutch companies are adopting advanced technologies such as AI, ML and real-time monitoring to strengthen cloud operations and security, the report says. Industries including healthcare and finance embrace robust security models such as zero trust to protect complex cloud environments. Amid this evolution, providers are addressing skills shortages by expanding managed services and automation, helping clients address cloud complexity. Enterprises in the Netherlands increasingly seek flexible, customized cloud solutions that go beyond basic infrastructure to support efficient workload migration, seamless integration and enhanced security for sensitive data, ISG says. Companies need these environments to ensure greater operational control, improved performance and adherence to evolving data protection regulations. 'Dutch enterprises are prioritizing adaptable cloud strategies to navigate changing technology demands,' said Meenakshi Srivastava, lead analyst, ISG Provider Lens Research, and lead author of the report. 'They prefer tailored services that simplify compliance while providing strong protection.' The report also explores other cloud trends in the Netherlands, including the requirement for cloud portability and interoperability to avoid vendor lock-in and the deployment of adaptive AI solutions to streamline complex business processes. For more insights into the cloud-related challenges faced by Dutch enterprises, along with ISG's advice for addressing them, see the ISG Provider Lens® Focal Points briefing here. The 2025 ISG Provider Lens® Private/Hybrid Cloud — Data Center Services report for the Netherlands evaluates the capabilities of 48 providers across three quadrants: Managed Services, Colocation Services and AI-Ready Infrastructure Consulting. The report names Accenture, Capgemini, Kyndryl and TCS as Leaders in two quadrants each. Atos, Cognizant, CyrusOne, Digital Realty, DXC Technology, Equinix, Eurofiber Cloud Infra, maincubes, NorthC Datacenters, NTT DATA, QTS and Wipro are named as Leaders in one quadrant each. In addition, LTIMindtree and nLighten are named as Rising Stars — companies with a 'promising portfolio' and 'high future potential' by ISG's definition — in one quadrant each. In the area of customer experience, Persistent Systems is named the global ISG CX Star Performer for 2025 among private/hybrid cloud and data center service providers. Persistent Systems earned the highest customer satisfaction scores in ISG's Voice of the Customer survey, part of the ISG Star of Excellence™ program, the premier quality recognition for the technology and business services industry. The 2025 ISG Provider Lens® Private/Hybrid Cloud — Data Center Services report for the Netherlands is available to subscribers or for one-time purchase on this webpage. About ISG Provider Lens® Research The ISG Provider Lens® Quadrant research series is the only service provider evaluation of its kind to combine empirical, data-driven research and market analysis with the real-world experience and observations of ISG's global advisory team. Enterprises will find a wealth of detailed data and market analysis to help guide their selection of appropriate sourcing partners, while ISG advisors use the reports to validate their own market knowledge and make recommendations to ISG's enterprise clients. The research currently covers providers offering their services globally, across Europe, as well as in the U.S., Canada, Mexico, Brazil, the U.K., France, Benelux, Germany, Switzerland, the Nordics, Australia and Singapore/Malaysia, with additional markets to be added in the future. For more information about ISG Provider Lens research, please visit this webpage. About ISG ISG (Nasdaq: III) is a global AI-centered technology research and advisory firm. A trusted partner to more than 900 clients, including 75 of the world's top 100 enterprises, ISG is a long-time leader in technology and business services that is now at the forefront of leveraging AI to help organizations achieve operational excellence and faster growth. The firm, founded in 2006, is known for its proprietary market data, in-depth knowledge of provider ecosystems, and the expertise of its 1,600 professionals worldwide working together to help clients maximize the value of their technology investments.